O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$139M
2
+$132M
3
+$110M
4
PFE icon
Pfizer
PFE
+$98.3M
5
GILD icon
Gilead Sciences
GILD
+$85.6M

Top Sells

1
+$372M
2
+$99.8M
3
+$98.1M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$68M

Sector Composition

1 Healthcare 97.58%
2 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
– –
-364,206
152
– –
-71,300
153
– –
-483,842
154
– –
0
155
– –
-68,400
156
– –
-131,653
157
– –
0
158
– –
-1,141,390
159
– –
-184,061
160
– –
-375
161
– –
-286,800
162
– –
-22,800
163
– –
0
164
– –
-27,900
165
– –
-2,577,982
166
– –
0
167
– –
-5,316,355
168
– –
-5,000,000
169
– –
0
3 4 5 6
7